What If We Solved Disease Before It Spikes?

Every year, millions of people across Africa are diagnosed too late.

Not because treatment doesn’t exist.
Not because innovation hasn’t advanced.
But because early detection never reached them.

Cancers that could have been caught at Stage I are discovered at Stage IV.
Diabetes goes undetected until complications become irreversible.
Tuberculosis, malaria, kidney disease, hormonal disorders — all escalate quietly, invisibly, until the cost is no longer just medical, but economic, social, and human.

What if we changed that?

What if early diagnostics became the first line of defense — not an afterthought?

The Preventable Tragedy

Across large parts of Africa, diagnostics remain centralized, invasive, expensive, and logistically complex. Blood-based testing requires trained staff, cold chains, clinics, and infrastructure that simply do not exist at scale — especially in rural and underserved communities.

The result:

Late-stage disease detection

Overburdened hospitals

Higher treatment costs

Lost productivity

Preventable deaths

This is not a technology problem.
It is a deployment problem.

A Different Starting Point: Saliva-Based Diagnostics

Saliva diagnostics change the equation entirely.

They are:

• Non-invasive
• Low-cost
• Easy to collect
• Scalable in community settings
• Suitable for molecular, protein, hormonal, metabolic, and infectious disease testing

When paired with local labs, tele-health follow-up, and national screening strategies, saliva diagnostics become a population-level prevention tool, not just a medical test.

More Than Health: An Economic Multiplier

This is where the opportunity becomes catalytic.

By pairing diagnostics with:

• Local manufacturing of collection devices
• Assembly and lab infrastructure
• Telehealth platforms
• Community health worker deployment

We do not just detect disease earlier — we:

• Create thousands of skilled jobs
• Retain healthcare spending locally
• Build sovereign diagnostic capacity
• Reduce long-term treatment costs
• Strengthen public health resilience

Health impact and economic development become one integrated system.

The Question for Foundations and Development Banks

This raises a simple but powerful question:

Would you support a program that prevents disease before it spikes — while creating jobs, building local industry, and strengthening national health systems?

Because that is exactly what we are proposing.

Through a tripartite partnership between:

• 360Disruption (execution, government alignment, FDI structuring)
• Oasis Diagnostics (saliva-based molecular and protein testing technologies)
• Oludent Health International (tele-health and care pathway integration)

we are building a scalable, funder-aligned diagnostics platform designed for Africa — starting with priority countries and expanding regionally.

This Is Not Aid. This Is Infrastructure.

We are not asking foundations to fund pilots that disappear when grants end.

We are inviting partners to co-build:

• National diagnostic capacity
• Local manufacturing ecosystems
• Sustainable screening programs
• Long-term health and economic resilience

Solve disease earlier. Save lives. Create jobs. Build sovereignty.

The Invitation

If you are a:

• Development bank
• Global foundation
• Impact investor
• Public-sector innovation fund

and you believe prevention beats cure — we invite you to engage.

What if we solved disease before it spikes?
Now is the moment to find out.